期刊文献+

Th17细胞及相关细胞因子在自身免疫性甲状腺疾病中的变化及意义 被引量:33

The change of Th17 lymphocytes and cytokines in autoimmune thyroid diseases
原文传递
导出
摘要 目的探究Th17细胞及相关细胞因子IL-17、IL-6在自身免疫性甲状腺疾病中的变化及意义。方法收集49例初发自身免疫性甲状腺疾病患者,根据病情分为Graves病初发组和桥本甲状腺炎初发组,随访至治疗后甲状腺功能正常,另设健康对照组。采用流式细胞仪检测外周血中Th17细胞比例,用双抗体夹心酶联法检测血浆IL-17、IL-6水平。结果 IL-17和IL-6在Graves病初发组、桥本甲状腺炎初发组中均明显升高。IL-6在Graves病缓解组中明显下降。IL-17在Graves病缓解组中,桥本甲状腺炎缓解组并无明显下降。Th17细胞在Graves病初发组、桥本甲状腺炎初发组中明显升高。Th17细胞比例与IL-17水平呈正相关,与IL-6无相关性。在桥本甲状腺炎中,Th17和IL-17水平与自身抗体TPO-Ab、TG-Ab呈正相关,在Graves病中,Th17和IL-17水平与特异性抗体TRAB无相关性。结论 Th17细胞可能参与了自身免疫性甲状腺疾病的发病,且与桥本甲状腺炎关系更为密切。 To examine the serum levels of Interleukin-17(IL-17),Interleukin-6(IL-6) and the proportion of peripheral of Th17 cells in human autoimmune thyroid diseases(AITD),we studied 30 patients with Graves' disease(GD) and 19 patients with Hashimoto's thyroiditis(HT) before and after treatment.The levels of IL-17 and IL-6 were measured by Double-antibody sandwich Enzymeimmunoassay.The Th17 lymphocytes cells were investigated by flow cytometry analysis.The serum levels of IL-17 and IL-6 increased in GD and HT patients.IL-17 levels were still higher than control group in euthyroid GD group and euthyroid HT group.The Th17 cells were increased in the GD group and HT group compared with control group.The proportion of peripheral Th17 cells had positive relationship with the level of IL-17 and had no relationship with the levels of IL-6.Both Th17 cells and IL-17 had positive relationship with the level of TPO-Ab,TG-Ab in HT and had no relationship with the level of TRAB in GD.The results suggest that IL-17 and Th17 cells may involve in the pathogenesis of AITD and especially in the HT disease.
出处 《免疫学杂志》 CAS CSCD 北大核心 2011年第9期785-788,共4页 Immunological Journal
基金 重庆市卫生局科研基金项目(2009-2-319)
关键词 TH17细胞 白介素17 GRAVES病 桥本甲状腺炎 Th17 cells Interleukin-17 Graves' disease Hashimoto's thyroiditis
  • 相关文献

参考文献10

  • 1梁亮,王红.Th17细胞与自身免疫性疾病[J].免疫学杂志,2010,26(3):264-266. 被引量:13
  • 2宋进展,吴汉妮,钱伟.慢性淋巴细胞性甲状腺炎患者外周血Th17的检测及意义[J].细胞与分子免疫学杂志,2009,25(10):927-928. 被引量:21
  • 3Miriam Beer Torchinsky,J. Magarian Blander.T helper 17 cells: discovery, function, and physiological trigger[J]. Cellular and Molecular Life Sciences . 2010 (9)
  • 4Nanba T,Watanabe M,Inoue N,et al.Increases of theTh1/Th2 cell ratio in severe hashimoto’’s disease and in theproportion of Th17 cells in intractable graves’’disease. Thyroid . 2009
  • 5Kolls JK,Linden A.Interleukin-17 family members and inflammation. Immunity . 2004
  • 6Hwang,SY,Kim,JY,KW.IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB- and PI3-kinase/Akt-dependent pathways. Arthritis Research and Therapy . 2004
  • 7Fujino S,Andoh A,Bamba S,et al.Increased expression of interleukin 17 in inflammatory bowel disease. Gut . 2003
  • 8Wang W,Milani M,Ostlie N,et al.C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis,suggesting a pathogenic role of nonTh1 cells. J Immunol . 2007
  • 9Nicte’’Figueroa-Vega,Manuel Alfonso-Pe’’rez,et al.IncreasedCirculating Pro-Inflammatory Cytokines and Th17 Lymphocytes in Hashi-moto’’s Thyroiditis. The Journal of Clinical Endocrinology . 2010
  • 10Borgogni E,Sarchielli E,Sottili M,et al.Elocalcitol inhibits in-flammatory responses in human thyroid cells and Tcells. The Journal of Endocrinology . 2008

二级参考文献26

  • 1Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORγt directs the differrentiation program of proinflammatory IL-17 ^+ T helper cells[J]. Cell, 2006, 126(6) : 1121 -1133.
  • 2Kikly K, Liu L, Na S, Sedgwick JD. The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation [J]. Curr Opin Immunol, 2006, 18(6) : 670 -675.
  • 3Yen D, Cheun GJ, Scheerens H, et al. IL-23 is essential for T cell- mediated colitis and promotes inflammation via IL-17 and IL-6 [ J]. J Clin Invest, 2006, 116 (5) : 1310 - 1316.
  • 4Kolls JK, Linden A. Interleukin-17 family members and inflammation [J].Immunity, 2004, 21(4): 467-476.
  • 5Korn T, Reddy J, Gao W, et al. Myelin-specific regulatory T ceils accumulate in the CNS but fail to control autoimmune inflammation[ J]. Nat Med, 2007, 13(4) : 423 -431.
  • 6Veldhoen M, Hocking R J, Atkins C J, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-Producing T Cells [J]. Immunity, 2006,24 (2): 179-189.
  • 7Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-betal controls T cell tolerance and regulates T h 1- and Th 17-cell differentiation [J]. Immunity, 2007, 26 (5): 579-591.
  • 8Thakker P, Leach MW, Kuang W, et al. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis[J]. J Immunol, 2007, 178 (4): 2589-2598.
  • 9Ivanov II, McKenzie BS, Zhou L, et al, The orphan nuclear receptor RORgarnmat directs the differentiation program of proinflammatory IL- 17^+ T helper cells [J]. Cell, 2006, 126 (6): 1121-1133.
  • 10Yang XO, Panopoulos AD, Nurieva R, et al. SATA3 regulates cytokine-mediated generation of inflammatory helper T cells[J]. J Biol Chem, 2007, 282 (13): 9 358-9 363.

共引文献32

同被引文献298

引证文献33

二级引证文献181

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部